A Philadelphia jury said Tuesday that Johnson & Johnson (NYSE:JNJ) should pay $2.5 million to a 20-year-old autistic man from Alabama – who developed size 46 DD breasts as a young teenager – because the company failed to adequately warn of that potential side effect from his use of the antipsychotic drug Risperdal. On Tuesday shares of Johnson & Johnson (NYSE:JNJ) closed at $100.70. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.82%.
Coherus Biosciences, Inc. (NASDAQ:CHRS) announced that it will present at the Cowen and Company 35th Annual Health Care Conference on Monday, March 2 at 4:10 pm ET in Boston. Coherus Biosciences, Inc. (NASDAQ:CHRS) in last trading activity moved up 6.23% to close at $29.86. Company weekly performance is 12.34% while its quarterly performance stands at 129.69%. Coherus Biosciences, Inc. (NASDAQ:CHRS) is -9.38% away from its 52 week high.
Hewlett-Packard Company (NYSE:HPQ) announced financial results for its fiscal 2015 first quarter ended January 31, 2015. For the fiscal 2015 second quarter, HP estimates non-GAAP diluted net EPS to be in the range of $0.84 to $0.88, reflecting an estimated currency impact of $0.09. On Tuesday shares of Hewlett-Packard Company (NYSE:HPQ) closed at $38.49. Company’s sales growth for last 5 years was -0.50% and EPS growth for next 5 years is recorded as 4.89%.
Xencor, Inc. (NASDAQ:XNCR) announced that it intends to offer and sell, subject to market and other conditions, up to 5,500,000 shares of its common stock in an underwritten public offering. Xencor expects to grant the underwriters a 30-day option to purchase up to an additional 825,000 shares of common stock offered in the public offering. Xencor, Inc. (NASDAQ:XNCR) has 0.20% insider ownership while its institutional ownership stands at 44.40%. In last trading activity company’s stock closed at $14.51.
On February 19, Denbury Resources Inc. (NYSE:DNR) reported fourth-quarter 2014 earnings of 27 cents per share (excluding one-time items), flat year over year. On last trading day Denbury Resources Inc. (NYSE:DNR) moved up 0.11% to close at $8.78. For full-year 2014, adjusted profit was $1.04 per share versus $1.46 in the prior year. The reported figure comfortably surpassed our expectation of $1.02. Its volatility for the week is 7.07% while volatility for the month is 7.38%. DNR’s sales growth for past 5 years was 22.30% and its EPS growth for past 5 years was 51.70%. Denbury Resources Inc. (NYSE:DNR) monthly performance is 30.07%.